Avid Bioservices Inc (CDMO)

[jakedogman1]

Blackrock also recently filed a 13 d for Halozyme

http://d18rn0p25nwr6d.cloudfront.net/CIK-0001159036/5e5b236d-43f9-48ba-a832-b1eeff86f5bf.pdf

after reading cdmo latest cc transcripts, all the "big" deals they are working on would probably require the ability for capacity expansion IMO... the clients are not going to saddle up with Avid unless Avid can handle program expansions... ie the sticky part of the equation.... my guess is an equity raise in the not to distant future to satisfy ability to expand... short term pressure on price but big rev expansion potential which is where valuation inflection point will be ... if correct on this assumption, the timing of contracts should mitigate pricing pressure... and AVID is at the mercy of clients in making any announcements....all imo